Johnson Matthey PLC (LON:JMAT – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 2,105.43 and traded as high as GBX 2,130. Johnson Matthey shares last traded at GBX 2,130, with a volume of 51,273,496 shares changing hands.
Wall Street Analyst Weigh In
Several research analysts have commented on JMAT shares. UBS Group reissued a “neutral” rating and issued a GBX 2,200 price objective on shares of Johnson Matthey in a research report on Friday. Deutsche Bank Aktiengesellschaft raised their target price on Johnson Matthey from GBX 1,922 to GBX 2,120 and gave the company a “buy” rating in a research note on Tuesday, April 7th. Finally, Berenberg Bank lowered their target price on Johnson Matthey from GBX 2,250 to GBX 2,100 and set a “buy” rating for the company in a research note on Monday, March 23rd. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of GBX 2,218.33.
Read Our Latest Analysis on JMAT
Johnson Matthey Stock Up 1.6%
Insider Activity
In other Johnson Matthey news, insider Andrew Cosslett bought 5,136 shares of the stock in a transaction dated Tuesday, February 24th. The stock was bought at an average cost of GBX 1,937 per share, for a total transaction of £99,484.32. Also, insider Liam Condon bought 14 shares of the stock in a transaction dated Wednesday, March 11th. The shares were acquired at an average price of GBX 1,941 per share, with a total value of £271.74. Insiders acquired 10,434 shares of company stock worth $20,144,228 over the last ninety days. Corporate insiders own 0.51% of the company’s stock.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Stories
- Five stocks we like better than Johnson Matthey
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
